Depomed, Mallinckrodt pain drug gets faster review

by admin on July 29, 2013

Depomed Inc. and Mallinckrodt PLC said Monday that the Food and Drug Administration plans to conduct a faster review of their pain drug MNK-795. The companies said the FDA will run a priority review of …

View full post on pain – Yahoo! News Search Results

Previous post:

Next post: